<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The recent American College of Gastroenterology Guidelines for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal Cancer</z:e> Screening highlight <z:mp ids='MP_0001261'>obese</z:mp> individuals as a high-risk group for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>In this issue, Okabayashi and colleagues present data from a well-designed and executed meta-analysis demonstrating an increased <z:mpath ids='MPATH_270'>adenoma</z:mpath> risk for a modest increase in body mass index (BMI) </plain></SENT>
<SENT sid="2" pm="."><plain>Specifically, overweight (BMIâ‰¥25) subjects have an increased risk for colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> (odds ratio=1.24 (95% confidence interval=1.16-1.33)) as compared with non-overweight subjects </plain></SENT>
<SENT sid="3" pm="."><plain>The paper's many strengths include the careful selection of the best studies </plain></SENT>
<SENT sid="4" pm="."><plain>These data highlight the importance of screening in <z:mp ids='MP_0001261'>obese</z:mp> patients </plain></SENT>
</text></document>